Interim analysis of the REASSURE (Radium-223 alpha Emitter Agent in non-intervention Safety Study in mCRPC popUlation for long-teRm Evaluation) study: patient characteristics and safety according to prior use of chemotherapy in routine clinical practice

S. Dizdarevic, P.M. Petersen, M. Essler, A. Versari, J.-C. Bourre, C. la Fougère, R. Valdagni, G. Paganelli, S. Ezziddin, J. Kalinovský, I. Bayh, Y. Du

Research output: Contribution to journalArticle

Cite this